Hepatobiliary disposition of valproic acid and valproate glucuronide: Use of a pharmacokinetic model to examine the rate-limiting steps and potential sites of drug interactions

Hepatology

Volumn 23, Issue 4, 1996, Pages 771-780

  Booth, Catherine L ^a   Pollack, Gary M ^a   Brouwer, Kim L R ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; DRUG METABOLITE; MORPHINE; PARACETAMOL; PHENOBARBITAL; TRITIUM; VALPROIC ACID;

ANIMAL CELL; ANTICONVULSANT THERAPY; ARTICLE; BILIARY EXCRETION; CELL MEMBRANE TRANSPORT; CONTROLLED STUDY; DRUG DIFFUSION; DRUG DISPOSITION; DRUG GLUCURONIDATION; DRUG TRANSFORMATION; LIVER CELL; LIVER METABOLISM; NONHUMAN; PRIORITY JOURNAL; RAT; SEIZURE;

EID: 0029876744     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.1996.v23.pm0008666331     Document Type: Article

References (9)

1. Vore M. Canalicular transport: discovery of ATP-dependent mechanisms. Toxicol Appl Pharmacol 1993;118:2-7.
2. Klaassen CD. Intestinal and hepatobiliary disposition of drugs. Toxicol Pathol 1988;16:130-137.
3. Brouwer KLR, Jones JA. Altered hepatobiliary disposition of acetaminophen metabolites after phenobarbital pretreatment and renal ligation: evidence for impaired biliary excretion and a diffusional barrier. J Pharmacol Exp Ther 1990;252:657-664.
4. Loeser W, Siegers CP. Effects of phenobarbital, phorone and carbon tetrachloride pretreatment on the biliary excretion of acetaminophen in rats. Arch Int Pharmacodyn Ther 1985;275:180-188.
5. Gregus Z, Madhu C, Klaassen CD. Effect of microsomal enzyme inducers on biliary and urinary excretion of acetaminophen metabolites in rats. Decreased hepatobiliary and increased hepatovascular transport of acetaminophen-glucuronide after microsomal enzyme induction. Drug Metab Dispos 1990; 18:10-19.
6. Roerig DL, Hasegawa AT, Peterson RE, Wang RIH. Effect of chloroquine and phenobarbital on morphine glucuronidation and biliary excretion in the rat. Biochem Pharmacol 1974;23:1331-1339.
7. Watkins JB, Klaassen CD. Effect of inducers and inhibitors of glucuronidation on the biliary excretion and choleretic action of valproic acid in the rat. J Pharmacol Exp Ther 1982;220:305-310.
8. Gugler R, von Unruh GE. Clinical pharmacokinetics of valproic acid. Clin Pharmacokinet 1980;5:67-83.
9. Schobben F, van der Kleijn E. Valproate: Biotransformation. In: Woodbury DM, Penry JK, Pippenger CE, eds. Antiepileptic drugs. New York: Raven Press, 1982:567-578.